InvestorsHub Logo
Followers 1
Posts 61
Boards Moderated 0
Alias Born 12/29/2011

Re: DewDiligence post# 4788

Wednesday, 08/10/2016 6:09:57 PM

Wednesday, August 10, 2016 6:09:57 PM

Post# of 108192
Not really.

JnJ and Amgen have vetted listeria as a immunotherapy platform through Aduro and ADXS now.

Just need to see combo results in November. The CR we saw early in the trial is encouraging, but would like to see results without impact of clinical hold.

Also I like that they are building up their own manufacturing capability. A lot of start ups just contract this out, even in the late phase and commercial. This shows good long term investment to grow.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News